- Home
- GRAF vs VNDA Comparison
GRAF vs VNDA Comparison
Compare GRAF & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAF
- VNDA
- Stock Information
- Founded
- GRAF 2021
- VNDA 2002
- Country
- GRAF United States
- VNDA United States
- Employees
- GRAF N/A
- VNDA N/A
- Industry
- GRAF
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- GRAF
- VNDA Health Care
- Exchange
- GRAF NYSE
- VNDA Nasdaq
- Market Cap
- GRAF 288.1M
- VNDA 270.2M
- IPO Year
- GRAF 2024
- VNDA 2006
- Fundamental
- Price
- GRAF $10.02
- VNDA $4.94
- Analyst Decision
- GRAF
- VNDA Strong Buy
- Analyst Count
- GRAF 0
- VNDA 2
- Target Price
- GRAF N/A
- VNDA $15.50
- AVG Volume (30 Days)
- GRAF 24.9K
- VNDA 643.5K
- Earning Date
- GRAF 01-01-0001
- VNDA 11-06-2024
- Dividend Yield
- GRAF N/A
- VNDA N/A
- EPS Growth
- GRAF N/A
- VNDA N/A
- EPS
- GRAF 0.25
- VNDA N/A
- Revenue
- GRAF N/A
- VNDA $190,858,000.00
- Revenue This Year
- GRAF N/A
- VNDA $5.13
- Revenue Next Year
- GRAF N/A
- VNDA $42.65
- P/E Ratio
- GRAF $40.39
- VNDA N/A
- Revenue Growth
- GRAF N/A
- VNDA N/A
- 52 Week Low
- GRAF $9.03
- VNDA $3.46
- 52 Week High
- GRAF $11.02
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- GRAF N/A
- VNDA 50.36
- Support Level
- GRAF N/A
- VNDA $4.82
- Resistance Level
- GRAF N/A
- VNDA $5.55
- Average True Range (ATR)
- GRAF 0.00
- VNDA 0.22
- MACD
- GRAF 0.00
- VNDA -0.02
- Stochastic Oscillator
- GRAF 0.00
- VNDA 32.22
About GRAF GRAF GLOBAL CORP
Graf Global Corp is a blank check company.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.